NIAGEN BIOSCIENCE, INC. (NAGE) Current Ratio
- Current ratio · latest quarter: Value 6.50×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 6.50× | Current assets / current liabilities. $97.79M ÷ $15.05M ≈ 6.50× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 97.79M USD | Assets, Current |
| Current obligations | 15.05M USD | Liabilities, Current |
| Cash and equivalents | (m) | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 8.58M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 20.64M USD | Inventory, Net |
| Payables | 9.44M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $97.79M | $15.05M | (m) | (m) | $8.58M | $20.64M | $9.44M | (m) | 6.50× |
| 2026-03-31 | $105.12M | $22.82M | (m) | (m) | $13.07M | $24.02M | $13.28M | (m) | 4.61× |
| 2025-12-31 | $96.81M | $19.92M | (m) | (m) | $9.74M | $20.42M | $10.80M | (m) | 4.86× |
| 2025-09-30 | $93.62M | $22.71M | $64.10M | (m) | $8.51M | $18.79M | $12.74M | (m) | 4.12× |
| 2025-06-30 | $86.68M | $22.33M | $60.30M | (m) | $9.66M | $14.41M | $13.68M | (m) | 3.88× |
| 2025-03-31 | $76.22M | $20.84M | $55.50M | (m) | $7.05M | $11.19M | $10.63M | (m) | 3.66× |
| 2024-12-31 | $64.10M | $17.95M | (m) | (m) | $7.77M | (m) | $8.53M | (m) | 3.57× |
| 2024-09-30 | $52.13M | $17.70M | $32.20M | (m) | $7.10M | $10.54M | $6.90M | (m) | 2.95× |
| 2024-06-30 | $49.30M | $17.87M | $27.70M | (m) | $7.82M | $11.51M | $8.11M | (m) | 2.76× |
| 2024-03-31 | $48.98M | $19.45M | $27.40M | (m) | $6.60M | $12.49M | $7.90M | (m) | 2.52× |
| 2023-12-31 | $49.53M | $20.62M | (m) | (m) | (m) | $14.53M | $10.23M | (m) | 2.40× |
| 2023-09-30 | $47.18M | $19.44M | $26.60M | (m) | (m) | $12.62M | $9.20M | (m) | 2.43× |
| 2023-06-30 | $46.38M | $19.06M | $26.30M | (m) | (m) | $11.97M | $10.03M | (m) | 2.43× |
| 2023-03-31 | $46.56M | $18.42M | $23.00M | (m) | $9.22M | $11.91M | $8.95M | (m) | 2.53× |
| 2022-12-31 | $46.57M | $17.87M | (m) | (m) | (m) | $14.68M | $9.68M | (m) | 2.61× |
| 2022-09-30 | $37.90M | $16.73M | $13.10M | (m) | $4.74M | $15.64M | $9.12M | (m) | 2.27× |
| 2022-06-30 | $38.51M | $17.73M | $16.90M | (m) | $4.23M | $15.75M | $10.20M | (m) | 2.17× |
| 2022-03-31 | $44.52M | $18.69M | $20.99M | (m) | $6.31M | $15.31M | $9.78M | (m) | 2.38× |
| 2021-12-31 | $48.91M | $17.61M | (m) | (m) | $5.23M | $13.60M | $10.42M | (m) | 2.78× |
| 2021-09-30 | $52.84M | $17.77M | $33.10M | (m) | $5.29M | $12.68M | $10.80M | (m) | 2.97× |
| 2021-06-30 | $57.93M | $16.23M | $38.78M | (m) | $6.00M | $12.18M | $9.97M | (m) | 3.57× |
| 2021-03-31 | $63.22M | $19.76M | $44.69M | (m) | (m) | $12.76M | $11.69M | (m) | 3.20× |
| 2020-12-31 | $32.22M | $16.48M | $16.70M | (m) | $2.69M | $11.68M | $9.45M | (m) | 1.96× |
| 2020-09-30 | $30.73M | $13.02M | $15.48M | (m) | (m) | $11.03M | $6.88M | (m) | 2.36× |
| 2020-06-30 | $35.77M | $16.04M | $18.89M | (m) | (m) | $12.34M | $9.78M | (m) | 2.23× |
| 2020-03-31 | $29.15M | $14.47M | (m) | (m) | $3.56M | $11.28M | $8.16M | (m) | 2.01× |
| 2019-12-31 | $33.52M | $15.06M | $18.81M | (m) | (m) | $11.54M | $9.63M | (m) | 2.23× |
| 2019-09-30 | $36.37M | $11.02M | (m) | (m) | $5.95M | $9.82M | $6.17M | (m) | 3.30× |
| 2019-06-30 | $37.52M | $24.21M | (m) | (m) | $5.74M | $10.71M | $9.32M | (m) | 1.55× |
| 2019-03-31 | $34.78M | $15.55M | (m) | (m) | $5.31M | $8.67M | $9.75M | (m) | 2.24× |
| 2018-12-31 | $36.53M | $14.44M | (m) | (m) | $4.36M | $8.25M | $9.55M | (m) | 2.53× |
| 2018-09-30 | $41.49M | $12.96M | (m) | (m) | $4.77M | $7.08M | $8.89M | (m) | 3.20× |
| 2018-06-30 | $46.48M | $10.96M | (m) | (m) | $5.13M | $6.53M | $6.76M | (m) | 4.24× |
| 2018-03-31 | $52.58M | $10.08M | (m) | (m) | $4.77M | $5.06M | $5.86M | (m) | 5.21× |
| 2017-12-30 | $57.18M | $8.09M | (m) | (m) | $5.34M | $5.80M | $3.72M | (m) | 7.07× |
| 2017-09-30 | $36.26M | $7.21M | (m) | (m) | $4.92M | $6.62M | $4.35M | (m) | 5.03× |
| 2017-07-01 | $27.38M | $6.26M | (m) | (m) | $4.58M | $7.79M | $3.13M | (m) | 4.37× |
| 2017-04-01 | $15.59M | $10.74M | (m) | (m) | $5.04M | $8.94M | $7.87M | (m) | 1.45× |
| 2016-12-31 | $15.74M | $8.87M | (m) | (m) | $5.85M | $7.91M | $5.98M | (m) | 1.77× |
| 2016-10-01 | $15.49M | $6.36M | (m) | (m) | $6.51M | $6.31M | $4.10M | (m) | 2.44× |
| 2016-07-02 | $15.15M | $4.79M | (m) | (m) | $6.79M | $4.52M | $2.33M | (m) | 3.17× |
| 2016-04-02 | $14.37M | $6.71M | (m) | (m) | $4.33M | $6.69M | $2.91M | (m) | 2.14× |
| 2016-01-02 | $16.55M | $9.59M | (m) | (m) | $2.45M | $8.17M | $6.22M | $1.53M | 1.73× |
| 2015-10-03 | $13.03M | $5.88M | (m) | (m) | $3.78M | $4.16M | $3.56M | (m) | 2.22× |
| 2015-07-04 | $12.31M | $5.03M | (m) | (m) | $3.10M | $3.09M | $3.09M | (m) | 2.45× |
| 2015-04-04 | $9.06M | $4.77M | (m) | (m) | $2.23M | $3.23M | $2.64M | (m) | 1.90× |
| 2015-01-03 | $9.90M | $4.98M | (m) | (m) | $1.91M | $3.73M | $3.45M | $223.36K | 1.99× |
| 2014-09-27 | $6.31M | $3.58M | (m) | (m) | $2.53M | $2.29M | $2.27M | (m) | 1.76× |
| 2014-06-28 | $6.58M | $3.98M | (m) | (m) | $2.12M | $2.87M | $2.76M | (m) | 1.65× |
| 2014-03-29 | $6.42M | $3.24M | (m) | (m) | $1.67M | $2.49M | $1.92M | (m) | 1.98× |
| 2013-12-28 | $5.79M | $2.84M | (m) | (m) | $838.79K | $2.20M | $1.44M | (m) | 2.04× |
| 2013-09-28 | $4.68M | $4.11M | (m) | (m) | $1.03M | $2.22M | $2.35M | (m) | 1.14× |
| 2013-06-29 | $4.64M | $3.36M | (m) | (m) | $1.19M | $1.94M | $2.15M | (m) | 1.38× |
| 2013-03-30 | $4.48M | $3.65M | (m) | (m) | $986.37K | $1.57M | $2.38M | (m) | 1.23× |
| 2012-12-29 | $7.93M | $4.76M | (m) | (m) | $1.94M | $5.21M | $3.43M | (m) | 1.66× |
| 2012-09-29 | $8.27M | $3.90M | (m) | (m) | $1.20M | $5.44M | $2.84M | (m) | 2.12× |
| 2012-06-30 | $8.98M | $4.25M | (m) | (m) | $988.20K | $5.25M | $3.40M | (m) | 2.11× |
| 2012-03-31 | $11.63M | $4.28M | (m) | (m) | $1.40M | $4.05M | $3.07M | (m) | 2.71× |
| 2011-12-31 | $4.95M | $3.34M | (m) | (m) | $723.67K | $2.91M | $2.25M | (m) | 1.48× |
| 2011-10-01 | $5.83M | $2.39M | (m) | (m) | $648.83K | $2.50M | $1.31M | (m) | 2.44× |
| 2011-07-02 | $5.53M | $2.19M | $2.04M | (m) | (m) | $1.97M | $1.36M | (m) | 2.52× |
| 2011-01-01 | $4.90M | $1.14M | (m) | (m) | $1.00M | $1.42M | $514.60K | (m) | 4.30× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |